Rapid diagnostics for influenza

Since January 2020, Wando has created various. diagnostic tools that detect the COVID-19 virus. These products were create using three. expert techniques: nucleic acid (RT-PCR), antigen, and antibody.

Background

Immunoassays known as rapid flu tests (RIDTs) can detect the presence. of influenza A and B viral nucleoprotein antigens in respiratory specimens and. present the result (positive vs. (1). Many RIDTs are offer in the United States. The reverse transcription-polymerase chain reaction. (RT-PCR) or viral culture is the reference standard for laboratory. confirmation of influenza virus infection in respiratory specimens. RIDTs can produce results in less than 15 minutes. which is a significant amount of time. But, RIDTs are less sensitive than RT-PCR. or viral culture to identify influenza viruses in respiratory specimens. Negative RIDT test findings should be interpret. due to the possibility of false negative results, particularly during. the peak influenza season in a community. To standardize result interpretation, certain RIDTs use analyzer reading equipment.

Benefits of RIDTs

Produce rapid results in under 15 minutes, with ease of execution

Some RIDTs can be use in offices or at bedsides. RIDTs that have had the CLIA waived may be use in point-of-care settings.

Clinical Decision-Making Using RIDTs

When making diagnoses and treatment choices. for patients in clinical settings, such as giving. them antiviral drugs, RIDTs may assist. Negative RIDT results do not rule out influenza virus infection in patients. with influenza-like symptoms and signs because of the restricted sensitivities. Antiviral treatment should, thus, not be withheld. from patients with suspected influenza. even if they test negative by RIDT if it is necessary. More influenza testing of respiratory materials by molecular tests may be necessary. More details of antiviral medications and suggestions for using them.

Factors Affecting RIDT Results

The accuracy of RIDTs can be affecte a variety of circumstances, including:

– Clinical indicators that state influenza

– Flu activity prevalence in the sampled population

– The interval between the onset of the disease. and the collection of the respiratory specimens for testing. – The type of respiratory specimen tested – The test’s accuracy in comparison to a reference test

-Details of the RIDT

Since January 2020, Wando has created various. diagnostic tools that detect the COVID-19 virus. These products were create using three expert techniques:. nucleic acid (RT-PCR), antigen, and antibody.

Background

Immunoassays known as rapid flu tests (RIDTs). can detect the presence of influenza A and B viral. nucleoprotein antigens in respiratory specimens and present the result (positive vs. (1). Many RIDTs are offere in the United States. The reverse transcription-polymerase chain reaction. (RT-PCR) or viral culture is the reference standard. for laboratory confirmation of influenza virus infection in respiratory specimens. RIDTs can produce results in less than 15 minutes. which is a significant amount of time. Yet, RIDTs are less sensitive than RT-PCR. or viral culture to identify influenza viruses in respiratory specimens. Negative RIDT test findings should be interprete. due to the possibility of false negative results, particularly during. the peak influenza season in a community. To standardize result interpretation, certain RIDTs use analyzer reading equipment.

Benefits of RIDTs

Produce rapid results in under 15 minutes, with ease of execution

Some RIDTs can be use in offices or at bedsides. RIDTs that have had the CLIA waived may be use in point-of-care settings.

Clinical Decision-Making Using RIDTs

When making diagnoses and treatment choices. for patients in clinical settings, such as giving. them antiviral drugs, RIDTs may assist. Negative RIDT results do not rule out influenza virus infection. in patients with influenza-like symptoms and signs because of the restricted sensitivities. Antiviral treatment should, thus, not be withheld. from patients with suspected influenza. even if they test negative by RIDT if it is necessary. More influenza testing of respiratory materials by molecular tests may be necessary. More details about antiviral medications and suggestions for using them.

Factors Affecting RIDT Results

The accuracy of RIDTs can affected a variety of circumstances, including:

– Clinical indicators that state influenza

– Flu activity prevalence in the sampled population

– The interval between the onset of the disease. and the collection of the respiratory specimens for testing. – The type of respiratory specimen tested – The test’s accuracy in comparison to a reference test

-Details of the RIDT